# Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease

> **NCT00376714** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 45 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK233705

## Key facts

- **NCT ID:** NCT00376714
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08-16
- **Primary completion:** —
- **Final completion:** 2007-04-03
- **Target enrollment:** 45 (—)
- **Last updated:** 2018-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376714, "Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00376714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*